J. Gene Wang, M.D., Ph.D.
Dr. J. Gene Wang is the CEO of Immetas Therapeutics, a biotech company he co-founded with David Sinclair at Harvard focusing on inflammation pathways in aging. He is a physician scientist with nearly two-decades experience in advancing scientific innovations across multiple therapeutic areas, including immunology/inflammation (Abbott, GSK & Novartis) and oncology (Merck). He created development strategies and led cross-functional teams in the successful development of Humira®, Varubi®, Zolinza® and Gardasil®. He also led efforts to identify novel targets and brought multiple first-in-class compounds to clinical-stage and proof-of-concept studies. Dr. Wang received M.D. from Peking University and Ph.D. in Immunobiology from Yale University, and he completed medical residency training at Yale New Haven Hospital.